Terms: = Thyroid cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA
273 results:
1. Application of fluorocarbon nanoparticles of
Zhi L; Cheng C; Jing L; Zhi-Ping P; Lu Y; Yan T; Zhi-Gang W; Guo-Bing Y
J Nanobiotechnology; 2024 Mar; 22(1):107. PubMed ID: 38475902
[TBL] [Abstract] [Full Text] [Related]
2. EphB3 protein is a potential ancillary diagnostic biomarker for thyroid cancers.
Gao X; Zhang R; He Y; Wang X; Bao W; Feng X; Chai J; Wang J
Ann Diagn Pathol; 2024 Apr; 69():152262. PubMed ID: 38150866
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma.
Attia AS; Hussein S; Sameh H; Khalil A; Waley AB; Matar I; Sameh R
Cancer Biomark; 2024; 39(3):211-221. PubMed ID: 38073379
[TBL] [Abstract] [Full Text] [Related]
4. Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma.
Wang CC; Lu DD; Shen MH; Chen RL; Zhang ZH; Lv JH
Diagn Pathol; 2023 Nov; 18(1):123. PubMed ID: 37951919
[TBL] [Abstract] [Full Text] [Related]
5. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract] [Full Text] [Related]
6. Feeding artery: a valuable feature for differentiation of regenerative nodule, dysplastic nodules and small hepatocellular carcinoma in CEUS LI-RADS.
Wu J; Zhao Q; Wang Y; Xiao F; Cai W; Liu S; Du Z; Yu X; Liu F; Yu J; Liang P
Eur Radiol; 2024 Feb; 34(2):745-754. PubMed ID: 37589899
[TBL] [Abstract] [Full Text] [Related]
7. Identification of Diagnostic Metabolic Signatures in thyroid Tumors Using Mass Spectrometry Imaging.
Mao X; Huang L; Li T; Abliz Z; He J; Chen J
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570761
[TBL] [Abstract] [Full Text] [Related]
8. Deep Learning-Based Differential Diagnosis of Follicular thyroid Tumors Using Histopathological Images.
Nojima S; Kadoi T; Suzuki A; Kato C; Ishida S; Kido K; Fujita K; Okuno Y; Hirokawa M; Terayama K; Morii E
Mod Pathol; 2023 Nov; 36(11):100296. PubMed ID: 37532181
[TBL] [Abstract] [Full Text] [Related]
9. Ultrasound features and risk stratification system in NIFT-P and other follicular-patterned thyroid tumors.
Matrone A; Gambale C; Pieroni E; De Napoli L; Torregrossa L; Materazzi G; Elisei R
Eur J Endocrinol; 2023 Aug; 189(2):175-182. PubMed ID: 37530386
[TBL] [Abstract] [Full Text] [Related]
10. Dual-targeting lanthanide-ICG-MOF nanoplatform for cancer Theranostics: NIR II luminescence imaging guided sentinel lymph nodes surgical navigation.
Lin B; Dai R; Liu Z; Li W; Bai J; Zhang G; Lv R
J Photochem Photobiol B; 2023 Aug; 245():112731. PubMed ID: 37331158
[TBL] [Abstract] [Full Text] [Related]
11. Glutathione-Exhausting Nanoprobes for NIR-II Fluorescence Imaging-Guided Surgery and Boosting Radiation Therapy Efficacy via Ferroptosis in Breast cancer.
Wei M; Bai J; Shen X; Lou K; Gao Y; Lv R; Wang P; Liu X; Zhang G
ACS Nano; 2023 Jun; 17(12):11345-11361. PubMed ID: 37272787
[TBL] [Abstract] [Full Text] [Related]
12. Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells.
Huang LT; Li TJ; Li ML; Luo HY; Wang YB; Wang JH
BMC Complement Med Ther; 2023 Apr; 23(1):130. PubMed ID: 37095470
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis.
Sun Z; Bai C; Su M; Tang H; Wu X; Wang Y; Bao H; Liu X; Wu X; Shao Y; Xu B
Mol Oncol; 2023 Sep; 17(9):1917-1929. PubMed ID: 37013911
[TBL] [Abstract] [Full Text] [Related]
14. Expression of micro-ribonucleic acids in thyroid nodules and serum to discriminate between follicular adenoma and cancer in patients with a fine needle aspiration biopsy classified as suspicious for follicular neoplasm: A preliminary study.
Świrta JS; Wątor G; Seweryn M; Kapusta P; Barczyński M; Wołkow P
Adv Clin Exp Med; 2023 Sep; 32(9):997-1007. PubMed ID: 36897102
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions.
Macerola E; Poma AM; Vignali P; Proietti A; Torregrossa L; Ugolini C; Basolo A; Matrone A; Elisei R; Santini F; Basolo F
J Endocrinol Invest; 2023 Aug; 46(8):1651-1662. PubMed ID: 36749451
[TBL] [Abstract] [Full Text] [Related]
16. The Role of Claudin-1 Expression in Follicular and Papillary thyroid Neoplasm.
Miskad UA; Aswidah A; Dahlan H; Ikram D; Cangara MH; Djimahit T; Kaelan C
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4023-4027. PubMed ID: 36579982
[TBL] [Abstract] [Full Text] [Related]
17. The potential diagnostic value of Rac1 immunohistochemistry in follicular thyroid carcinoma.
Agustina H; Ahyati R; Suryanti S; Hernowo BS
Malays J Pathol; 2022 Aug; 44(2):225-233. PubMed ID: 36043585
[TBL] [Abstract] [Full Text] [Related]
18. Proteotypic Differences of Follicular-Patterned thyroid Neoplasms.
Huang D; Zhang H; Li L; Ge W; Liu W; Dong Z; Gao J; Yao N; Fu W; Huang L; Guo T; Sun Y; Teng X
Front Endocrinol (Lausanne); 2022; 13():854611. PubMed ID: 35923625
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathologic features of thyroid nodules with PTEN mutations on preoperative testing.
Quaytman JA; Nikiforov YE; Nikiforova MN; Morariu E
Endocr Relat Cancer; 2022 Sep; 29(9):513-520. PubMed ID: 35723418
[TBL] [Abstract] [Full Text] [Related]
20. Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples.
Dell'Aquila M; Tralongo P; Granitto A; Martini M; Capodimonti S; Curatolo M; Fiorentino V; Pontecorvi A; Fadda G; Lombardi CP; Raffaelli M; Pantanowitz L; Larocca LM; Rossi ED
J Clin Pathol; 2023 Oct; 76(10):671-677. PubMed ID: 35701142
[TBL] [Abstract] [Full Text] [Related]
[Next]
